Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Senators, providers urge narrow pilot to study psilocybin therapy in licensed clinics
Summary
A joint committee hearing heard proponents call for a tightly controlled pilot to study psilocybin and similar psychedelic-assisted therapies in licensed medical settings and to distinguish that approach from last year’s broader ballot question.
Senate and House committee members heard testimony on S.1400, a bill authorizing a limited pilot to study the use of psychedelics in licensed mental‑health treatment settings.
Proponents told the Joint Committee on Mental Health, Substance Use and Recovery that the measure would allow carefully supervised, medical research into psychedelic‑assisted therapy while avoiding broad decriminalization measures voters rejected last year. Senator Eric Friedman, speaking virtually, said the bill would authorize up to three specialized clinics to use psychedelics under DPH…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
